1-500 | 501-907
    Part,  Chapter, Paragraph

501   II,     9.  5.  3    |                 arms or legs (17%), skin diseases, infectious diseases, asthma
502   II,     9.  5.  3    |                skin diseases, infectious diseases, asthma and allergies (European
503   II,     9.  5.  4    |               prevention of communicable diseases, health determinants (alcohol,
504   II,     9.  5.  4    |           programmes for high prevalence diseases among men such as lung cancer (
505   II,     9.  5.  4    |        information messages. Examples of diseases relevant to gender research
506   II,     9.  5.  4    |              research are cardiovascular diseases - e.g. acute coronary syndrome -
507   II,     9.  5.  6    |              Mental Health~ ~Centers for Diseases Control and Prevention (
508  III,    10.  1        |             environmental pollutants and diseases being considered, but are
509  III,    10.  1        |              public health and potential diseases with the ambition to assess
510  III,    10.  1        |                factors. Of the 102 major diseases, disease groupings and injuries
511  III,    10.  1        |          associations vary for different diseases/exposures – from a very
512  III,    10.  1        |       environmental exposures~Infectious diseases~water, air and food contamination~
513  III,    10.  1        |                 dioxins~ ~Cardiovascular diseases~air pollution (carbon monoxide,
514  III,    10.  1        |         cholesterol~stress~ ~Respiratory diseases, including asthma~smoking
515  III,    10.  1        |                  and excreta~damp~ ~Skin diseases~UV radiation~Some metals
516  III,    10.  1.  1    |                disease and other chronic diseases (Burke et al, 1995; Green
517  III,    10.  1.  1    |         cardiovascular and other chronic diseases. In this regard, effectiveness
518  III,    10.  2.  1    |            Product~NCDs~Non-communicable diseases~NRT~Nicotine replacement
519  III,    10.  2.  1    |                  causing a wide range of diseases, 24 of which are fatal.
520  III,    10.  2.  1    |            Cancers (43%), cardiovascular diseases (28%) and respiratory diseases (
521  III,    10.  2.  1    |           diseases (28%) and respiratory diseases (18%) together account for
522  III,    10.  2.  1    |                 only two smoking related diseases (COPD and CVD) for the EU
523  III,    10.  2.  1    |               world (WHO, 2008). All the diseases caused by direct smoke and
524  III,    10.  2.  1    |               death.~ ~Table 10.2.1.1.1. Diseases caused by smoking and by
525  III,    10.  2.  1    |                 CDC (2004); CDC (2006)~ ~Diseases caused by smoking~Diseases
526  III,    10.  2.  1    |               Diseases caused by smoking~Diseases caused by second-hand smoke~
527  III,    10.  2.  1    |        second-hand smoke~Cancers~Chronic diseases~Childen~Adults~Larinx~Stroke~
528  III,    10.  2.  1    |          delivery*~Bladder~ ~ ~ ~For the diseases caused by second-hand smoke:
529  III,    10.  2.  1    |         suggestive~ ~ ~Table 10.2.1.1.2. Diseases and adverse health effects
530  III,    10.  2.  1    |                      Cancers~Respiratory diseases and adverse health effects~
531  III,    10.  2.  1    |            health effects~Cardiovascular diseases and adverse health effects~
532  III,    10.  2.  1    |          Maternal and Child Health~Other diseases and adverse health effects~-
533  III,    10.  2.  1    |            increased risk of respiratory diseases in children and young people
534  III,    10.  2.  1    |                from smoking attributable diseases in all EU countries (Figure
535  III,    10.  2.  1    |               for the main categories of diseases for the year 2000.~ ~Table
536  III,    10.  2.  1    |                from smoking attributable diseases in all EU countries. Female
537  III,    10.  2.  1    |                  causing a wide range of diseases and a massive burden of
538  III,    10.  2.  1    |            mortality from cardiovascular diseases. It has a synergistic effect
539  III,    10.  2.  1    |                in 2000, non-communicable diseases (NCDs) accounted for about
540  III,    10.  2.  1    |            services) for smoking related diseases among smokers and second-hand
541  III,    10.  2.  1    |            categories of smoking related diseases: COPD and CVD, in Europe
542  III,    10.  2.  1    |                 fact that only two major diseases have been included, and
543  III,    10.  2.  1    |                  different disorders and diseases with short and long-term
544  III,    10.  2.  1    |            several other alcohol-related diseases such as ischemic heart disease
545  III,    10.  2.  1    |                the EU15), ischemic heart diseases (northern Europe) and cancer (
546  III,    10.  2.  1    |       Investigation into Cancer, Chronic Diseases, Nutrition and Lifestyle~http ~ ~
547  III,    10.  2.  1    |              physical health (infectious diseases, cirrhosis, cancer) problems
548  III,    10.  2.  1    |                  drug related infectious diseases; (iv) drug-related deaths
549  III,    10.  2.  1    |            HIV/AIDS and other infectious diseases among drug users. While
550  III,    10.  2.  1    |                the spread of blood borne diseases (mainly HIV/Aids and hepatitis
551  III,    10.  2.  1    |           response to prevent infectious diseases in most EU countries. While
552  III,    10.  2.  1    |              major risk factors for oral diseases are the same as for major
553  III,    10.  2.  1    |                 chronic non-communicable diseases such as obesity, heart disease,
554  III,    10.  2.  1    |             reducing the burden of these diseases. This common-risk approach
555  III,    10.  2.  1    |          concerns the early diagnosis of diseases.~ ~Oral health, particularly
556  III,    10.  2.  1    |                  care in childhood. Oral diseases, mainly caries and gengivities,
557  III,    10.  2.  1    |         gengivities, are the most costly diseases. Promotion of oral health
558  III,    10.  2.  1    |                  in preventing most oral diseases. However, optimal intervention
559  III,    10.  2.  1    |               primary prevention of oral diseases, poses a considerable challenge
560  III,    10.  2.  1    |               and control of periodontal diseases. Gingivitis can be prevented
561  III,    10.  2.  1    |        non-communicable and communicable diseases, and into maternal and child
562  III,    10.  2.  1    |              major risk factors for oral diseases are the same as for major
563  III,    10.  2.  1    |                 chronic non-communicable diseases such as obesity, heart disease,
564  III,    10.  2.  1    |             reducing the burden of these diseases. This common-risk approach
565  III,    10.  2.  1    |          concerns the early diagnosis of diseases. The common-risk approach
566  III,    10.  2.  1    |                 simply tackling specific diseases to objectives expressed
567  III,    10.  2.  1    |               high risk of specific oral diseases and involves improving access
568  III,    10.  2.  1    |                  dental and craniofacial diseases can be achieved. Lifestyle
569  III,    10.  2.  1    |                   Although common dental diseases are preventable, not all
570  III,    10.  2.  1    |             epidemiology and periodontal diseases. In: Bourgeois DM, Llodra
571  III,    10.  2.  1    |                The global burden of oral diseases and risk to oral heath.
572  III,    10.  2.  1    |                 chronic non-communicable diseases causing about 3.5% of the
573  III,    10.  2.  1    |                  obesity-related chronic diseases, such as type II diabetes
574  III,    10.  2.  1    |          overweight, obesity and chronic diseases (European Commission, 2005b,
575  III,    10.  2.  1    |          overweight, obesity and chronic diseases. Brussels, Commission of
576  III,    10.  2.  1    |              Control of Non-communicable Diseases, Copenhagen, WHO Regional
577  III,    10.  2.  1    |                    There are a number of diseases induced by an excessive
578  III,    10.  2.  1    |                them (i.e. cardiovascular diseases, cancer and diabetes) have
579  III,    10.  2.  1    |               medical costs to treat the diseases associated with it (direct
580  III,    10.  2.  1    |        respectively. Prevalence of these diseases is particularly significant
581  III,    10.  2.  1    |         Overweight and obesity and other diseases related to nutritional unbalances~ ~
582  III,    10.  2.  1    |                comparisons. As for other diseases related to nutritional unbalances,
583  III,    10.  2.  1    |            Region (James et al, 2004).~ ~Diseases associated to nutritional
584  III,    10.  2.  1    |                  risk for cardiovascular diseases.~Surveys have shown that
585  III,    10.  2.  1    |             prevalence of cardiovascular diseases in Europe that are a leading
586  III,    10.  2.  1    |                associated to a number of diseases and disturbances such as
587  III,    10.  2.  1    |           infertility and cardiovascular diseases (Brown & Arthur, 2001; Chen &
588  III,    10.  2.  1    |                 in the absence of severe diseases, age-related physiological
589  III,    10.  2.  1    |                the Prevention of Chronic Diseases” (2003).~· WHO Global Strategy
590  III,    10.  2.  1    |          overweight, obesity and chronic diseases (European Commission, 2005b;
591  III,    10.  2.  1    |            diet-related non-communicable diseases, obesity in children and
592  III,    10.  2.  1    |              deficiencies and food-borne diseases.~· European Parliament resolution
593  III,    10.  2.  1    |                 obesity and diet-related diseases such as cardiovascular disease,
594  III,    10.  2.  1    |           treatment of nutrition-related diseases).~· Monitoring, evaluation
595  III,    10.  2.  1    |          overweight, obesity and chronic diseases. Brussels, Commission of
596  III,    10.  2.  1    |          overweight, obesity and chronic diseases”. National Institute for
597  III,    10.  2.  1    |                the prevention of chronic diseases. Report of a Joint WHO/FAO
598  III,    10.  2.  1    |               cardiovascular and related diseases. Croatian Medical Journal
599  III,    10.  2.  1    |    selenoproteins in the brain and brain diseases. J Neurochem. 86: 1-12.~ ~
600  III,    10.  2.  1    |          overweight, obesity and chronic diseases. Green paper, Brussels,
601  III,    10.  2.  4    |            Statistical Classification of Diseases and Related~ ~Health Problems~
602  III,    10.  2.  4    |         underlying biological factors of diseases such as genomic variants.
603  III,    10.  2.  4    |                measure the prevalence of diseases if the surveillance is purely
604  III,    10.  2.  4    |              understanding of health and diseases as well as new concepts
605  III,    10.  2.  4    |              prevalence and incidence of diseases but they are not designed
606  III,    10.  2.  4    |              systems biology and complex diseases is discussed mainly in the
607  III,    10.  2.  4    |               often named multifactorial diseases. Still, the statistical
608  III,    10.  2.  4    |        occurrence and prevalence of such diseases. The Wellcome Trust Case
609  III,    10.  2.  4    |          controls for seven major common diseases (Wellcome Trust 2007).~ ~
610  III,    10.  2.  4    |                 on Rare Diseases). These diseases are monogenic and have a
611  III,    10.  2.  4    |                   For the multifactorial diseases which constitute the main
612  III,    10.  2.  4    |            haplotype variants, to common diseases. The new technologies will
613  III,    10.  2.  4    |             relation to the causation of diseases like cardiovascular diseases ,
614  III,    10.  2.  4    |             diseases like cardiovascular diseases , allergies, cancer, psychiatric
615  III,    10.  2.  4    |                  disorders or infectious diseases. There are already many
616  III,    10.  2.  4    |               the risk of cardiovascular diseases and dementia or as the interaction
617  III,    10.  2.  4    |                  myeloma, coronary heart diseases, pre-menopausal breast cancer,
618  III,    10.  2.  4    |           regarding the understanding of diseases, due to novel genome-based
619  III,    10.  2.  4    |               and sex standardisation of diseases);~· the differentiation
620  III,    10.  2.  4    |          susceptibility genes in complex diseases being associated to more
621  III,    10.  2.  4    |           decreases the risk for certain diseases;~· the shift from carrier
622  III,    10.  2.  4    |            triggering role of infectious diseases such as human papilloma
623  III,    10.  2.  4    |               the development of complex diseases and health problems;~· correlation
624  III,    10.  2.  4    |             severity and prolongation of diseases as well as with response
625  III,    10.  2.  4    |        monogenetic as well as to complex diseases) on the one hand and tests
626  III,    10.  2.  4    |               the one hand and tests for diseases with high penetrance (referring
627  III,    10.  2.  4    |                 referring to monogenetic diseases as well to complex diseases
628  III,    10.  2.  4    |              diseases as well to complex diseases following a mendelian trait)
629  III,    10.  2.  4    |                 penetrance (most complex diseases) on the other hand; and~·
630  III,    10.  2.  4    |                  the field of infectious diseases the situation is slightly
631  III,    10.  2.  4    |             impossible not only to group diseases according to ICD10, but
632  III,    10.  2.  4    |        communicable and non-communicable diseases and also between rare and
633  III,    10.  2.  4    |                  between rare and common diseases may no longer be valid:
634  III,    10.  2.  4    |                  valid: non-communicable diseases are triggered by communicable
635  III,    10.  2.  4    |                triggered by communicable diseases (e.g. obesity by adenoviruses)
636  III,    10.  2.  4    |                000 cases of seven common diseases and 3,000 shared controls.
637  III,    10.  2.  5    |      malnutrition with risk for physical diseases later in life. Empirical
638  III,    10.  2.  5    |               For a detailed analysis of diseases prevalent in different age
639  III,    10.  3.  1    |        documented associations with some diseases, annoyance and other impacts.
640  III,    10.  3.  1    |                    For neurodegenerative diseases and brain tumours, the link
641  III,    10.  3.  1    |                Mcelroy et al, 2007). For diseases other than cancer, very
642  III,    10.  3.  1    |                depression. Many of these diseases increase with age and therefore
643  III,    10.  3.  1    |              having more time to develop diseases with long latency. During
644  III,    10.  3.  2    |         contaminated food and infectious diseases, the WHO recently concluded
645  III,    10.  3.  2    |                  four priority groups of diseases: childhood cancer, childhood
646  III,    10.  3.  2    |              potential pollution-induced diseases is much longer and also
647  III,    10.  3.  2    |                 longer and also includes diseases of adults. The European
648  III,    10.  3.  2    |                  four priority groups of diseases or physiological disturbances.
649  III,    10.  3.  2    |              between chemicals and human diseases/disorders. The associations
650  III,    10.  3.  2    |       environmental exposures~Infectious diseases~water, air and food contamination~
651  III,    10.  3.  2    |                 dioxins~ ~Cardiovascular diseases~air pollution (carbon monoxide,
652  III,    10.  3.  2    |         cholesterol~stress~ ~Respiratory diseases, including asthma~smoking
653  III,    10.  3.  2    |                  and excreta~damp~ ~Skin diseases~UV radiation~Some metals
654  III,    10.  3.  3    |                 ECDC~European Centre for Diseases Control~MRSA~Methicillin-Resistant
655  III,    10.  3.  3    |                  variety of communicable diseases. Of the 49 diseases under
656  III,    10.  3.  3    |         communicable diseases. Of the 49 diseases under surveillance by the
657  III,    10.  3.  3    |                  the European Centre for Diseases Control (ECDC), 21 have
658  III,    10.  3.  3    |                  of the six communicable diseases with the highest incidence
659  III,    10.  3.  3    |               group, and include the two diseases with the highest crude incidence
660  III,    10.  3.  3    |        represents a great concern. In 22 diseases, the age groups most affected
661  III,    10.  3.  3    |               comes to the global killer diseases TB, malaria, HIV and pneumococcal
662  III,    10.  3.  3    |        infections do occur. Zoonoses are diseases or infections, which are
663  III,    10.  3.  3    |             humans, the gravity of these diseases can vary from mild symptoms
664  III,    10.  3.  3    |            biological hazards~ ~For some diseases there has been a significant
665  III,    10.  3.  3    |              threats detected (2005) for diseases reported on EU-level~ ~
666  III,    10.  3.  4    |         infectious, respiratory and skin diseases, and mental health problems~
667  III,    10.  3.  4    |                 and water- and foodborne diseases~Increased incidence of extreme
668  III,    10.  3.  4    |                  several climate-related diseases, providing advice on how
669  III,    10.  3.  4    |            Children, people with chronic diseases and those confined to bed,
670  III,    10.  3.  4    |           cardiovascular and respiratory diseases. People with chronic debilitating
671  III,    10.  3.  4    |                with chronic debilitating diseases are more at risk. These
672  III,    10.  3.  4    |             These include cardiovascular diseases, respiratory insufficiency,
673  III,    10.  3.  4    |            vector-borne and rodent-borne diseases), acute or chronic effects
674  III,    10.  3.  4    |                  related and water-borne diseases and illness, vector-borne
675  III,    10.  3.  4    |                and illness, vector-borne diseases, rodent-borne disease to
676  III,    10.  3.  4    |              waterborne and vector-borne diseases, rodent-borne diseases such
677  III,    10.  3.  4    |      vector-borne diseases, rodent-borne diseases such as leptospirosis, snake
678  III,    10.  3.  4    |               deficiencies), respiratory diseases and waterborne diseases
679  III,    10.  3.  4    |                  diseases and waterborne diseases in developing countries.
680  III,    10.  3.  4    |             pneumonia, upper respiratory diseases, asthma and chronic obstructive
681  III,    10.  3.  4    |            chronic obstructive pulmonary diseases . Pollutants from forest
682  III,    10.  4.  1    |            burden of environment-related diseases. Air pollution, mainly by
683  III,    10.  4.  1    |                    Much of the burden of diseases resulting from air pollutants
684  III,    10.  4.  1    |                later development of many diseases that present themselves
685  III,    10.  4.  1    |                  environmentally-related diseases in Europe. Recent estimates
686  III,    10.  4.  1    |           respiratory and cardiovascular diseases.~ ~The loss of statistical
687  III,    10.  4.  1    |        sensitized to allergens, allergic diseases may increase in Europe in
688  III,    10.  4.  2    |                of actions against animal diseases that can be transmitted
689  III,    10.  4.  2    |        eradication programmes for animal diseases and zoonoses under Council
690  III,    10.  4.  2    |               diagnosis of the following diseases in animals: classical swine
691  III,    10.  4.  2    |                  vesicular disease, fish diseases, bivalve mollusc diseases,
692  III,    10.  4.  2    |                diseases, bivalve mollusc diseases, rabies (vaccination monitoring),
693  III,    10.  4.  2    |               the many infectious animal diseases.~ ~The ADNS is a notification
694  III,    10.  4.  2    |                outbreaks of these animal diseases in the countries that are
695  III,    10.  4.  2    |           outbreaks of contagious animal diseases and enables Member States
696  III,    10.  4.  2    |            spread of the above mentioned diseases.~ ~The same Directive lays
697  III,    10.  4.  2    |                  these contagious animal diseases.~ ~On the internet page
698  III,    10.  4.  2    |                  the OIE the main animal diseases, including zoonoses. The
699  III,    10.  4.  2    |               Member Countries on animal diseases and zoonoses prior to 2005
700  III,    10.  4.  2    |                  of Transboundary Animal Diseases (GF-TADs) is a joint FAO/
701  III,    10.  4.  2    |             against transboundary animal diseases (TADs), provide for capacity
702  III,    10.  4.  2    |                 Systems for major animal diseases.~ ~ ~An important information
703  III,    10.  4.  2(33)|                  control of communicable diseases in the Community (OJ L 268,
704  III,    10.  4.  2    |            humans, the severity of these diseases can vary from mild symptoms
705  III,    10.  4.  2    |                 Table 10.4.2.2. Zoonotic diseases and food-born outbreaks
706  III,    10.  4.  2    |                other food-borne zoonotic diseases to reduce public health
707  III,    10.  4.  2    |                 food safety because some diseases, the so-called zoonoses
708  III,    10.  4.  2    |                  certain zoonotic animal diseases, which can be transferred
709  III,    10.  4.  2    |             animal waste.~ ~Zoonoses are diseases or infections, which are
710  III,    10.  4.  2    |            humans, the severity of these diseases can vary from mild symptoms
711  III,    10.  4.  2    |                In order to prevent these diseases from occurring, it is important
712  III,    10.  4.  2    |                 data covered 16 zoonotic diseases. Assisted by its Zoonoses
713  III,    10.  4.  2    |                  also important zoonotic diseases, with considerable incidences
714  III,    10.  4.  2    |          relevant due to severity of the diseases. Trichinella was rarely
715  III,    10.  4.  2    |             being officially free of the diseases or reporting no positive
716  III,    10.  4.  2    |               towards eradication of the diseases is slow in some of the non
717  III,    10.  4.  2    |             prevent or treat food animal diseases, through the use of food
718  III,    10.  4.  3    |            drinking-water.~ ~Water-borne diseases arise from the contamination
719  III,    10.  4.  3    |                 mortality and diarrhoeal diseases are the main health effects
720  III,    10.  4.  3    |                  of age due to diarrheal diseases in EUGLOREH Countries. Data
721  III,    10.  4.  3    |          mortality rates from diarrhoeal diseases are higher in low income
722  III,    10.  4.  3    |                rate (SMR) for diarrhoeal diseases in children under 5 years
723  III,    10.  4.  3    |                 to induce cardiovascular diseases and probably also neuro-developmental
724  III,    10.  4.  3    |               and reducing water-related diseases. The Protocol is the first
725  III,    10.  4.  3    |                 drinking water. Priority diseases selected for target setting
726  III,    10.  4.  3    |               typhoid fever, followed by diseases induced by Campylobacter,
727  III,    10.  4.  3    |                  reporting of waterborne diseases. Many countries, however,
728  III,    10.  4.  5    |                  with swimming and other diseases if ingested.~ ~Use of recreational
729  III,    10.  4.  5    |         unpleasant odours. Several human diseases have been reported to be
730  III,    10.  5.  1    |                   hygiene and infectious diseases is probably very important,
731  III,    10.  5.  1    |             mostly related to infectious diseases) and the psychological effects
732  III,    10.  5.  1    |                  of suspected waterborne diseases to the National Public Health
733  III,    10.  5.  1    |              including some communicable diseases. Homeless people tend to
734  III,    10.  5.  1    |               community for communicable diseases. The estimated population
735  III,    10.  5.  2    |            greater prevalence of chronic diseases which is posing a challenge
736  III,    10.  5.  2    |         pregnancies, infections, chronic diseases, acute somatic symptoms
737  III,    10.  5.  2    |                  more often with chronic diseases such as heart disease, stroke
738  III,    10.  5.  2    |               health outcomes from other diseases such as asthma (Jones and
739  III,    10.  5.  2    |                for some animal-triggered diseases, such as tick-borne diseases,
740  III,    10.  5.  2    |             diseases, such as tick-borne diseases, there is now an increasing
741  III,    10.  5.  2    |               only possible for specific diseases or disease groups, such
742  III,    10.  5.  2    |                 to an under-reporting of diseases in rural settings). However,
743  III,    10.  5.  3    |               accidents and occupational diseases which are only a small portion
744  III,    10.  5.  3    |              portion of the work-related diseases. The main strength of work-related
745  III,    10.  5.  3    |             information on the burden of diseases on work is provided followed
746  III,    10.  5.  3    |                 European data sources on diseases as a rule do not include
747  III,    10.  5.  3    |            includes data on occupational diseases following standards developed
748  III,    10.  5.  3    |               Statistics on Occupational Diseases. The project was aimed at
749  III,    10.  5.  3    |               indicators on occupational diseases in Europe by collecting
750  III,    10.  5.  3    |                 Schedule of Occupational Diseases were collected in 1998.
751  III,    10.  5.  3    |                 Schedule on Occupational Diseases. The statistics are based
752  III,    10.  5.  3    |       case-by-case data for occupational diseases recognised by the national
753  III,    10.  5.  3    |                 Force Survey covered all diseases, disabilities and other
754  III,    10.  5.  3    |               and analysis~The burden of diseases to the world of work~ ~This
755  III,    10.  5.  3    |           chapter presents the impact of diseases on work. This relationship
756  III,    10.  5.  3    |                 on the impact of work on diseases. However, private companies
757  III,    10.  5.  3    |                 services are affected by diseases and accidents through absenteeism
758  III,    10.  5.  3    |                 absence from work due to diseases and by reduced productivity
759  III,    10.  5.  3    |                  been calculated for all diseases but are available for cardiovascular
760  III,    10.  5.  3    |             available for cardiovascular diseases (CVD) as well as for mental
761  III,    10.  5.  3    |                  mental disorders - both diseases being of high public health
762  III,    10.  5.  3    |         conditions on the development of diseases and is centred around the
763  III,    10.  5.  3    |             definitions for occupational diseases, the termwork-related
764  III,    10.  5.  3    |                   the termwork-related diseases” has several different meanings.
765  III,    10.  5.  3    |                   including occupational diseases. There are several ways
766  III,    10.  5.  3    |                  figures on occupational diseases and work accidents. This
767  III,    10.  5.  3    |                employees.~ ~Occupational diseases~ ~Only a limited number
768  III,    10.  5.  3    |                 Only a limited number of diseases are recognized as being
769  III,    10.  5.  3    |        recognised non fatal occupational diseases occurred in Europe additionally
770  III,    10.  5.  3    |                 most common occupational diseases were hand or wrist tenosynovitis,
771  III,    10.  5.  3    |                 affected by occupational diseases (table 10.5.3.4). A top
772  III,    10.  5.  3    |            incident rate of occupational diseases.~ ~Table 10.5.3.3. Number
773  III,    10.  5.  3    |                of non fatal occupational diseases by ICD10.~ ~Table 10.5.3.
774  III,    10.  5.  3    |                of non fatal occupational diseases per economic sector~ ~According
775  III,    10.  5.  3    |                  recognised occupational diseases. An updated comparison of
776  III,    10.  5.  3    |               the risk of cardiovascular diseases.~ ~Consequences of these
777  III,    10.  5.  3    |                  reduce risk factors and diseases and show a positive return-on-investment.
778  III,    10.  5.  3    |             Promoting health, preventing diseases and returning to work~ ~
779  III,    10.  5.  3    |               accidents and occupational diseases beyond the workplace has
780  III,    10.  5.  3    |             still too many accidents and diseases caused by work and there
781  III,    10.  5.  3    |               accidents and occupational diseases by identifying and preventing
782  III,    10.  5.  3    |            reduction of risk factors and diseases and have a positive return-on-investment.~
783  III,    10.  5.  3    |                  insurance institutions.~Diseases often have multiple causes.
784  III,    10.  5.  3    |                 5. Future developments~ ~Diseases most often have multiple
785  III,    10.  5.  3    |                 report on cardiovascular diseases and mental ill health. Essen.
786  III,    10.  5.  3    |                  funding of occupational diseases in Europe. Paris. www r.
787  III,    10.  5.  3    |                 burden of cardiovascular diseases in the enlarged European
788  III,    10.  5.  3    |               statistics of occupational diseases~ESAW~European statistics
789  III,    10.  6.  2    |                in the EU, cardiovascular diseases are the main causes of inequalities,
790  III,    10.  6.  2    |              declines for cardiovascular diseases. In many Western European
791  III,    10.  6.  2    |              prevalence of most specific diseases (including mental illness)
792  III,    10.  6.  2    |             indicating that most chronic diseases have a higher prevalence
793  III,    10.  6.  2    |                  2.1. Odds Ratio Chronic diseases in eight European countries~
794  III,    10.  6.  2    |                 and incidence of certain diseases; and ensuring more effective
795  III,    10.  6.  2    |          protection against communicable diseases~8. Safe sexuality and good
796  III,    10.  6.  2    |             prevalence of common chronic diseases: an overview of eight European
797   IV                   |               PUBLIC HEALTH AND TREATING DISEASES: HEALTH SYSTEMS, SERVICES
798   IV,    11.  1.  5    |              should be used for specific diseases and conditions based on
799   IV,    11.  1.  5    |                  performance on specific diseases and interventions. In the
800   IV,    11.  2        |                the management of chronic diseases. There is growing attention
801   IV,    11.  2.  1    |                and complexity of chronic diseases. DMPs emphasise prevention
802   IV,    11.  2.  1    |          programmes extend beyond single diseases to more integrated approaches,
803   IV,    11.  2.  2    |      rare diseases and pollution-related diseases. The latest of the EU’s
804   IV,    11.  3.  2    |                development into priority diseases.~ ~Figure 11.5. Current
805   IV,    11.  3.  2    |            development into WHO priority diseases in the developed world (
806   IV,    11.  4        |                technologies for specific diseases, such as Diabetes type-2
807   IV,    11.  5.  1    |                 infectious or neoplastic diseases, establishing a consensus
808   IV,    11.  5.  3    |                  donor samples and prion diseases, where a considerable proportion
809   IV,    11.  6.  2    |                  UK~ ~Certain infectious diseases:~- Austria~ ~Certain chronic
810   IV,    11.  6.  2    |           chronic conditions and serious diseases:~- Belgium~- Finland~- Greece~-
811   IV,    11.  6.  2    |     Czech Republic~ ~Related to specific diseases (e.g. diabetes, epilepsy,
812   IV,    11.  6.  2    |             leprosy, syphilis, cancerous diseases):~- Estonia~ ~Considered
813   IV,    11.  6.  4    |             latest treatment methods for diseases and injuries should be promoted
814   IV,    11.  6.  4    |                 for most of the selected diseases, whereas clinical records
815   IV,    11.  6.  4    |                  available only for some diseases. Automatic linkage between
816   IV,    11.  6.  4    |               possible only for very few diseases and in few countries, given
817   IV,    12.  1        |     health-related of the population, on diseases and health systems based
818   IV,    12.  1        |                 indicators.~Communicable diseases~The objectives of the programme
819   IV,    12.  1        |            morbidity due to communicable diseases.~Cancer~The Community action
820   IV,    12.  1        |                  information about these diseases.~Injury prevention~The aim
821   IV,    12.  1        |               injuries~Pollution-related diseases~The aim was to contribute
822   IV,    12.  1        |          prevention of pollution-related diseases, including the improvement
823   IV,    12.  1        |             preventing human illness and diseases, and obviating sources of
824   IV,    12.  1        |                  prevalence of different diseases, medical culture, demography
825   IV,    12.  2        |               control tools for selected diseases~Cardiovascular diseases (
826   IV,    12.  2        |                  diseases~Cardiovascular diseases (CVD)~ ~Blood lipid and
827   IV,    12.  2        |             other major non-communicable diseases.~ ~In 2006, a large conference
828   IV,    12.  2        |       Investigation into Cancer, Chronic Diseases, Nutrition and Lifestyle~http
829   IV,    12.  4        |              waiting time and nosocomial diseases); and~· patient safety.~ ~ ~
830   IV,    12.  4        |               health posed by infectious diseases.~ ~ECHA~ ~European Chemicals
831   IV,    12.  5        |        communicable and non-communicable diseases and health threats from
832   IV,    12.  5        |                 of life and reduce major diseases and injuries by tackling
833   IV,    12.  5        |                of the population, and on diseases and health systems, based
834   IV,    12.  5        |               surveillance of infectious diseases which has been one of the
835   IV,    12.  5        |                 Sentinel Networks (e. g. diseases not under mandatory surveillance)~-
836   IV,    12.  5        |                 g. Notifiable Infectious diseases)~- Administrative data (
837   IV,    12.  5        |               protect health and prevent diseases. One of the main aims of
838   IV,    12.  8        |                exception of communicable diseases and development aid, the
839   IV,    12.  8        |                  control of communicable diseases in the Community Their experts
840   IV,    12.  9        |            activities related to poverty diseases;~international Conference
841   IV,    12. 10        |                  V (prevention of dental diseases): nutritional advice is
842   IV,    12. 10        |               SGB V prevention of dental diseases: prophylaxis for groups
843   IV,    12. 10        |               SGB V prevention of dental diseases: prophylaxis for individuals;
844   IV,    12. 10        |         programme to combat work-related diseases (Modellprogramm zur Bekämpfung
845   IV,    12. 10        |               rehabilitation of concrete diseases, prevention or improvement
846   IV,    12. 10        |                engineering and epizootic diseases. Gene therapy as well is
847   IV,    12. 10        |                and management of chronic diseases including diabetes, htt l~
848   IV,    12. 10        |          immunisation against infectious diseases, food/water/air safety,
849   IV,    12. 10        |                 for HIV and transmission diseases~ ~The Hellenic Centre for
850   IV,    12. 10        |                  The Hellenic Centre for Diseases Control and Prevention (
851   IV,    12. 10        |               other sexually transmitted diseases (i.e. Hepatitis B & C, HPV,
852   IV,    12. 10        |                 the sexually transmitted diseases. ~The department of HCDCP
853   IV,    12. 10        |               Reporting Centers for some diseases (e.g AIDS, Influenza, Hepatitis
854   IV,    12. 10        |                obesity and the metabolic diseases in Greece" as well as "the
855   IV,    12. 10        |              regards reports, we mention diseases specialised reports issued
856   IV,    12. 10        |           Hellenic Center for Infectious Diseases Control (www ~ ~COUNTRY:
857   IV,    12. 10        |                  and sexual communicable diseases: prevention part~Personal
858   IV,    12. 10        |               health: determinants, main diseases, work related health, age
859   IV,    12. 10        |                 of patients with chronic diseases, health and violence (this
860   IV,    12. 10        |                 starting) cardiovascular diseases, asthma, diabetes, health
861   IV,    12. 10        |             reports, we can also mention diseases specialised reports issued
862   IV,    12. 10        |            targetReducing communicable diseases, incl.HIV/AIDS” in national
863   IV,    12. 10        |                Reducing non-communicable diseases, incl. cardiovascular diseases”
864   IV,    12. 10        |           diseases, incl. cardiovascular diseases” in national Public Health
865   IV,    12. 10        |                Control of Cardiovascular Diseases~Interactions amongst determinants~
866   IV,    12. 10        |             prevention of cardiovascular diseases, screening for risk factors,
867   IV,    12. 10        |          Determinants for cardiovascular diseases~ Media campaign~ ~ ~COUNTRY:
868   IV,    12. 10        |              prevent major public health diseases by reducing obesity as well
869   IV,    12. 10        |           Mortality from alcohol-related diseases or injuries~Domain of objective
870   IV,    12. 10        |                 measures~Work accidents/ diseases~ ~Systematic work environment
871   IV,    12. 10        |          protection against communicable diseases~8. Safe sexuality and a
872   IV,    13.Acr        |      rare diseases and pollution-related diseases. The latest of the EU’s
873   IV,    13.Acr        |            Documents to control specific diseases or health determinants.~ ~
874   IV,    13.  1        |                 of many non-communicable diseases and associated mortality
875   IV,    13.  2.  1    |            effectively prevent and treat diseases, it is very important to
876   IV,    13.  2.  1    |             health loss due to different diseases or underlying risk factors.
877   IV,    13.  2.  1    |                  health effects and both diseases and mortality more directly
878   IV,    13.  2.  1    |                be calculated for various diseases using statistical information
879   IV,    13.  2.  1    |                  fraction of one or more diseases which can be explained by
880   IV,    13.  2.  2    |                        13.2.2. Burden of diseases~ ~Environmental burden of
881   IV,    13.  2.  2    |              countries, acute infectious diseases still cause most of the
882   IV,    13.  2.  2    |            high-income countries chronic diseases at older ages (cardiopulmonary
883   IV,    13.  2.  2    |              older ages (cardiopulmonary diseases and cancer) dominate the
884   IV,    13.  2.  2    |          primarily related to infectious diseases, indoor air pollution and
885   IV,    13.  2.  2    |                of the burden of specific diseases are shown in Table 13.5.~ ~ ~
886   IV,    13.  2.  2    |                 estimations of burden of diseases and selected health determinants~·
887   IV,    13.  2.  3    |                        13.2.3. Burden of diseases attributable to specific
888   IV,    13.  2.  3    |                  a number of significant diseases. The comparison shows that
889   IV,    13.  2.  3    |              loss due to the most common diseases in the Netherlands, including
890   IV,    13.  2.  3    |                 including coronary heart diseases and depression. Table 13.
891   IV,    13.  2.  3    |                of significant infectious diseases such as AIDS. In the case
892   IV,    13.  2.  3    |                 Smoking~ ~Cardiovascular diseases, all cancers~100,000-300,
893   IV,    13.  2.  3    |       physical activity~ ~Coronary heart diseases,~Depression, lung cancer,
894   IV,    13.  2.  3    |               relation to cardiovascular diseases and the relevant types of
895   IV,    13.  2.  3    |           consumptions on cardiovascular diseases, diabetes mellitus and the
896   IV,    13.  2.  3    |                  prevents cardiovascular diseases, as compared to total abstinence.
897   IV,    13.  2.  4    |                 2.4. Avoidable Burden of diseases.~ ~The WHO (2005) presented
898   IV,    13.  3        |            time-trends of most different diseases prevalence and incidence
899   IV,    13.  5        |              younger population. Chronic diseases may contribute to the gradual
900   IV,    13.  5        |            percent after age 90. Chronic diseases are a heavy burden on older
901   IV,    13.  5        |                 and incidence of certain diseases; and ensuring more effective
902   IV,    13.  5        |                for coping with different diseases is uneven. The data reported
903   IV,    13.  5        |              waiting time and nosocomial diseases); and~· patient safety.~ ~
904   IV,    13.  7.  3    |                problem (e.g., infectious diseases and environmental issues),
905   IV,    13.  7.  5    |             behaviour of the population, diseases and health systems at European
906   IV,    13.  7.  5    |        minorities, morbidity and chronic diseases, use of cross-border health
907   IV,    13.  9        |              Treatment of Ageing-related Diseases, Technical Report, OECD